Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Silo Pharma Inc (NQ: SILO ) 2.160 -0.310 (-12.55%) Streaming Delayed Price Updated: 3:17 PM EDT, Jul 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Silo Pharma Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > 12 Health Care Stocks Moving In Monday's Pre-Market Session March 20, 2023 Via Benzinga Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder March 15, 2023 Three companies have provided updates on their efforts to assess different psychedelics for treating a widely varied set of conditions. Via Benzinga PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Positive Results from IND-Enabling Toxicology Study of SP-26 March 15, 2023 Via Investor Brand Network Exposures Product Safety Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia March 15, 2023 From Silo Pharma, Inc. Via GlobeNewswire Silo Pharma Inc. (NASDAQ: SILO) Set to Benefit as Study Supports the Efficacy of Psychedelics in Treating ‘Drug-Resistant’ Depression March 13, 2023 Via Investor Brand Network Exposures COVID-19 Here Are The Year's Highest Priced Psychedelics Stocks In US Markets March 06, 2023 After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on. Via Benzinga PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands Intellectual Property, Technology Rights for Treating Rare Stress-Related Medical Conditions March 03, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Stocks That Hit 52-Week Lows On Tuesday February 28, 2023 During Tuesday, 79 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Monday February 27, 2023 During Monday's session, 56 companies made new 52-week lows. Via Benzinga Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced Disorders February 22, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Alzheimer’s February 13, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s February 13, 2023 From Silo Pharma, Inc. Via GlobeNewswire BioMedNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Partnering to Transform Health Care, Improve Patient Outcomes February 07, 2023 Via Investor Brand Network Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Expanded February 03, 2023 Silo Pharma Sees Growth In IP With New US Patent For Novel Ketamine Method On Stress-Induced Affective Disorders Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session February 02, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 02, 2023 Via Benzinga PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands IP Portfolio with New USPTO Patent February 02, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Silo Pharma Announces Expansion of Intellectual Property Portfolio February 02, 2023 Silo Receives Issuance of U.S. Patent Covering SPC-15 Method for Treatment and Prevention of Stress-Induced Affective Disorders From Silo Pharma, Inc. Via GlobeNewswire PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Board Authorizes Stock Repurchase Program January 31, 2023 Via Investor Brand Network Silo Pharma Announces Stock Repurchase Program January 31, 2023 From Silo Pharma, Inc. Via GlobeNewswire Silo Pharma Inc. (NASDAQ: SILO) Provides Update on UCSF Psylocibin Clinical Trial January 26, 2023 Via Investor Brand Network PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Eying Broad Market Opportunities for Its Liposomal Joint Homing Peptide January 20, 2023 Via Investor Brand Network Silo Pharma Inc. (NASDAQ: SILO) Provides Positive Update on Ongoing Study into the Use of Joint Homing Peptides as an Alternative Treatment for Rheumatoid Arthritis January 12, 2023 Via Investor Brand Network InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances Clinical Study Examining Psilocybin’s Effect on Inflammation January 10, 2023 Via Investor Brand Network Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation January 10, 2023 From Silo Pharma, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday January 06, 2023 During Friday's trading, 71 companies set new 52-week lows. Via Benzinga Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 03, 2023 Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group. Via Benzinga InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Reports Positive Results from SPU- 21 Arthritis Study January 03, 2023 Via Investor Brand Network What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways January 03, 2023 What a year for psychedelics! Via Benzinga Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket January 03, 2023 Gainers Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.